Strong M&A Activity, Stagnant Share Prices Await Genomics Sector in 2002 | GenomeWeb

SAN FRANCISCO, Jan. 7 - Smaller genomics, proteomics, and bioinformatics companies will look to take part in mergers and acquisitions in 2002 while bigger firms will seek to find those missing pieces that will let them make the jump from tool and tech shop to drug discoverer, the managing director of healthcare banking at JPMorgan H&Q said on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."